Lateral-flow device for diagnosis of fungal infection

Current Fungal Infection Reports

Volumn 7, Issue 3, 2013, Pages 244-251

  Thornton, Christopher R ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

glucan; Aspergillosis; Aspergillus; Candida; Cryptococcus; Galactomannan; Hybridoma technology; Lateral flow device; Monoclonal antibody

Indexed keywords

GALACTOMANNAN; GALLIUM 68; GLIOTOXIN; IMMUNOGLOBULIN G3; MANNOPROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY JF5; SIDEROPHORE; UNCLASSIFIED DRUG;

ARTICLE; CRYPTOCOCCUS; DIAGNOSTIC EQUIPMENT; EARLY DIAGNOSIS; ELECTRON TRANSPORT; ENZYME IMMUNOASSAY; FUNGAL BIOMASS; GENE EXPRESSION PROFILING; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOFLUORESCENCE; INVASIVE ASPERGILLOSIS; LATERAL FLOW DEVICE; LUNG ASPERGILLOSIS; LUNG LAVAGE; NONHUMAN; PHAGOCYTE; POINT OF CARE TESTING; POSITRON EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; SEROLOGY; SYSTEMIC MYCOSIS;

EID: 84883466385     PISSN: 19363761     EISSN: 1936377X     Source Type: Journal    
DOI: 10.1007/s12281-013-0138-x     Document Type: Article

References (57)

1. Thompson GR, Patterson TF. Pulmonary aspergillosis. Semin Respir Crit Care Med. 2008;29:103-10.
2. Miceli MH, Díaz JA, Lee SA. Emerging opportunistic yeast infections. Lancet Infect Dis. 2011;11:142-51.
3. Walsh TJ, Groll AH, Hiemenz J. Infections due to emerging and uncommon medically important fungal pathogens. Clin Microbiol Infect. 2004;10:48-66.
4. • Dagenais TRT, Keller NP. Pathogenesis of Aspergillus fumigatus in invasive aspergillosis. Clin Microbiol Rev. 2009;22(3):447-65. A contemporary review of the biology of A. fumigatus, airway colonization, adaptation to the mammanlian lung environment and its interaction with cells of the immune system.
5. Ainsworth GC: Aspergillosis. In Introduction to the history of medical and verterinary mycology. Cambridge University Press; 2002:47-9.
6. Thornton CR. Development of an immunochromatographic lateral flow device for rapid serodiagnosis of invasive aspergillosis. Clin Vacc Immunol. 2008;15:1095-105.
7. Beirão F, Araujo R. State of the art diagnostic of mould diseases: a practical guide for clinicians. Eur J Clin Microbiol Infect Dis. 2012. doi: 10.1007/s10096-012-1722-7.
8. Johnson GL, Bibby DF, Wong S, et al. A MIQE-Compliant Real-Time PCR Assay for Aspergillus Detection. PLoS One. 2012;7(7):e40022.
9. Denning DW. Invasive aspergillosis. Clin Infect Dis. 1998;26:781-805.
10. • Levitz SM. Innate recognition of fungal cell walls. PLoS Pathog. 2010;6(4):e1000758. This article reviews current knowledge of how the human host recognizes fungal pathogens through cell wall ligands and cognate phagocytic receptors.
11. Bozza S, Gaziano R, Spreca A, et al. Dendritic cells transport conidia and hyphae of Aspergillus fumigatus from the airways to the draining lymph nodes and initiate disparate Th reponses to the fungus. J Immunol. 2002;168:1362-71.
12. • Barton R, (2013). Laboratory diagnosis of invasive aspergillosis: from diagnosis to prediction to outcome. Scientifica, Hindawi Publishing Corporation. Available at http://www.hindawi.com/journals/scientifica/2013/ 459405/Accessed January 2013. A comprehensive review of the laboratory diagnosis of invasive aspergillosis.
13. Thornton CR. Detection of Invasive Aspergillosis. Adv Appl Microbiol. 2008;7:187-216.
14. •• De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organisation for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46:1813-21. This article defines the diagnostic criteria needed to establish possible, probable, or proven invasive fungal disease, and is a revised version of the 2002 consensus group guidelines.
15. •• White PL, Parr C, Thornton C, et al. An evaluation of real-time PCR, galactomannan ELISA and a novel lateral-flow device for diagnosis of invasive aspergillosis. 2013;51:1510-16. A large-scale evaluation of LFD diagnosis of IA, using serum from haematological patients, and comparison of assay sensitivity and specificity as a stand-alone test or when used in combination with commercial GM-EIA and PCR assays.
16. • Thornton CR, Johnson G, Agrawal S. Detection of invasive pulmonary aspergillosis in haematological malignancy patients by using lateral-flow technology. J Vis Exp. 2012;61:e3721. An open-access video journal demonstrating the mechanics of the Aspergillus LFD, serum and BALf preparation, and interpretation of test results using human BALf samples.
17. Hsu JL, Ruoss SJ, Bower ND, et al. Diagnosing invasive fungal infections in critically ill patients. Crit Rev Microbiol. 2011;37(4):277-312.
18. Obayashi T, Negishi K, Suzuki T, et al. Reappraisal of the serum (1→3)-β-D-glucan assay for the diagnosis of invasive fungal infections - a study based on autopsy cases from 6 years. Clin Infect Dis. 2008;46(12):1864-70.
19. Verweij PE, Mennink-Kersten MASH. Issues with galactomannan testing. Med Mycol. 2006;44:179-83.
20. Klont RR, Mennink-Kersten MA, Verweij PE. Utility of Aspergillus antigen detection in specimens other than serum specimens. Clin Infect Dis. 2004;15:1467-74.
21. Park SY, Lee S-O, Choi S-H, et al. Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis. J Infect. 2010;61:492-8.
22. •• Hoenigl M, Koidl C, Duettman W, et al. Bronchoalveolar lavage lateral-flow device test for invasive pulmonary aspergillosis diagnosis in haematological malignancy and solid organ transplant patients. J Infect. 2012;65:588-91. LFD detection of IA using human BALf samples and its performance compared to the commercial Platelia GM-EIA.
23. Buess M, Cathomas G, Halter J, et al. Aspergillus-PCR in brochoalveolar lavage for detection of invasive pulmonary aspergillosis in immunocompromised patients. BMC Infect Dis. 2012;12:237-44.
24. McDonagh A, Federova ND, Crabtree J, et al. Sub-telomere directed gene expression during initiation of invasive aspergillosis. PLoS Pathogens. 2008;4(9):e1000154.
25. Cairns T, Minuzzi F, Bignell E. The host-infecting fungal transcriptome. FEMS Microbiol Lett. 2010;307:1-11.
26. Gardiner DM, Waring P, Howlett BJ. The epipolythiodioxopiperazine (ETP) class of fungal toxins: distribution, mode of action, functions and biosynthesis. Microbiology. 2005;151:1021-32.
27. Spikes S, Xu R, Nguyen CK, et al. Gliotoxin production in Aspergillus fumigatus contributes to host-specific differences in virulence. J Infect Dis. 2008;197:479-86.
28. Sutton P, Newcombe NR, Waring P, et al. In vivo immunosuppressive activity of gliotoxin, a metabolite produced by human pathogenic fungi. Infect Immun. 1994;62:1192-8.
29. Pardo J, Urban C, Galvez EM, et al. The mitochondrial protein Bak is pivotal for gliotoxin-induced apoptosis and a critical host factor of Aspergillus fumigatus virulence in mice. J Cell Biol. 2006;174:509-19.
30. Sugui JA, Pardo J, Chang YC, et al. Gliotoxin is a virulence factor of Aspergillus fumigatus: gliP deletion attenuates virulence in mice immunosuppressed with hydrocortisone. Eukaryot Cell. 2007;6:1562-9.
31. Domingo MP, Colmenarejo C, Martínez-Lostao L, et al. Bis(methyl)gliotoxin proves to be a more stable and reliable marker for invasive aspergillosis than gliotoxin and suitable for use in diagnosis. Diagn Microbiol Infect Dis. 2012;73:57-64.
32. Eisendle M, Schrettl M, Kragl C, et al. The intracellular siderophore ferricrocin is involved in iron storage, oxidative-stress resistance, germination, and sexual development in Aspergillus nidulans. Eukaryot Cell. 2006;5:1596-603.
33. Haas H, Schoeser M, Lesuisse E, et al. Characterisation of the Aspergillus nidulans transporters for the siderophores enterobactin and triacetylfusarinine C. Biochem J. 2003;371:505-13.
34. 68Ga-Siderophores for PET imaging of invasive aspergillosis:proof of principle. J Nucl Med. 2010;51:639-45.
35. Schrettl M, Kim HS, Eisendle M, et al. SreA-mediated iron regulation in Aspergillus fumigatus. Mol Microbiol. 2008;70:27-43.
36. Zou M, Tang L, Zhao S, et al. Systematic review and meta-analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis. PLoS One. 2012;7(8):e43347.
37. Köhler G, Milstein C. Continuous culture of fused cells secreting antibody of predefined specificity. Nature. 1975;256:495-7.
38. Hirschi S, Letscher-Bru V, Pottecher J, et al. Disseminated Trichosporon mycotoxinivorans, Aspergillus fumigatus and Scedosporium apiospermum coinfection after lung and liver transplantation in a cystic fibrosis patient. J Clin Microbiol. 2012;50:4168-70.
39. Iweala OI. HIV diagnostic tests: an overview. Contraception. 2004;70:141-7.
40. Shyu RH, Shyu HF, Liu HW, et al. Colloidal gold-based immunochromatographic assay for detection of ricin. Toxicon. 2002;40:255-8.
41. Smits HL, Eapen CK, Sugathan S, et al. Lateral-flow assay for rapid serodiagnosis of human leptospirosis. Clin Diagn Lab Immunol. 2001;8:166-9.
42. Marot-Leblond A, Grimaud L, David S, et al. Evaluation of a rapid immunochromatographic assay for identification of Candida albicans and Candida dubliniensis. J Clin Microbiol. 2004;42(11):4956-60.
43. Jarvis NJ, Percival A, Bauman S, et al. Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis. Clin Infect Dis. 2011;53:1019-23.
44. Krajaejun T, Imkhieo S, Intaramat A, et al. Development of an immunochromatographic test for rapid serodiagnosis of human pythiosis. Clin Vacc Immunol. 2009;16:506-9.
45. Marcilla A, Monteagudo C, Mormeneo S, et al. Monoclonal antibody 3H8: a useful tool in the diagnosis of candidiasis. Microbiology. 1999;145:695-701.
46. Marot-Leblond A, Grimaud L, Nail S, et al. New monoclonal antibody specific for Candida albicans germ tube. J Clin Microbiol. 2000;38:61-7.
47. Brandt S, Thorkildson P, Kozel TR. Monoclonal antibodies reactive with immunorecessive epitopes of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans. Clin Diagn Lab Immunol. 2003;10:903-9.
48. Percival A, Thorkildson P, Kozel TR. Monoclonal antibodies specific for immunorecessive epitopes of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcocus neoformans, reduce serotype bias in immunoassay for cryptococcal antigen. Clin Vacc Immunol. 2011;18:1292-6.
49. Wiederhold NP, Thornton CR, Najvar LK, et al. Comparison of lateral flow technology and galactomannan and (1→3)-β-D-glucan assays for detection of invasive pulmonary aspergillosis. Clin Vacc Immunol. 2009;16:1844-6.
50. •• Wiederhold NP, Najvar LK, Bocanegra R, et al. Inter-Laboratory and Inter-Study Reproducibility of a Novel Lateral-Flow Device and the Influence of Antifungal Therapy on the Detection of Invasive Pulmonary Aspergillosis. J Clin Microbiol. 2013;51:459-65. A study using serum and BALf from an established animal model of IA, comparing the LFD, and commercial GM-EIA and β-glucan tests for disease diagnosis and the effect of antifungal treatments on assay sensitivities.
51. McCulloch E, Ramage G, Rajendran R, et al. Antifungal treatment affects the laboratory diagnosis of invasive aspergillosis. J Clin Pathol. 2012;65:83-6.
52. Buchheidt D. Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies. J Antimicrob Chemother. 2012;67:2260-7.
53. Vanselow M, Brandt ME, Park BJ. Diagnosis and management of Cryptococcal disease in resource-limited settings. Curr Fungal Infect Rep. 2012
54. O'Farrell B. Evolution of lateral flow-based immunoassay systems. In: Wong R, Tse H, editors. In Lateral Flow Immunoassay. New York: Humana Press; 2009. p. 1-35.
55. Marcos JY, Pincus DH. Fungal diagnostics: review of commercially available methods. In: O'Connor L, Glynn B, editors. Fungal Diagnostics: Methods and Protocols, Methods in Molecular Biology. 968th ed. New York: Springer Science and Business Media; 2013. p. 25-54.
56. Thornton CR. Tracking the emerging human pathogen Pseudallescheria boydii by using highly specific monoclonal antibodies. Clin Vacc Immunol. 2009;16:756-64.
57. Thornton CR, Wills O. Immunodetection of fungal and oomycete pathogens: established and emerging threats to human health, animal welfare and global food security. Crit Rev Microbiol. 2013, in press.